Generic Origin

Generic Origin is a biotechnology company headquartered in South San Francisco, California, dedicated to developing high-quality biologics and "bio-better" therapeutics. The company was founded by industry veterans from Amgen and other leading biopharma firms with the goal of making advanced protein-based medicines more accessible and affordable. Generic Origin utilizes a proprietary technology platform for protein engineering and high-titer cell line development to optimize the production and efficacy of monoclonal antibodies and other recombinant proteins. Their current research and development efforts are primarily focused on therapeutic areas such as oncology and immunology. By streamlining the development process from discovery to manufacturing, the company aims to deliver clinically validated treatments with improved performance profiles.